Back to Search Start Over

Fungicidal Synergism of Fluconazole and Cyclosporine in Candida albicansIs Not Dependent on Multidrug Efflux Transporters Encoded by the CDR1, CDR2, CaMDR1, and FLU1Genes

Authors :
Marchetti, Oscar
Moreillon, Philippe
Entenza, Josè M.
Vouillamoz, Jacques
Glauser, Michel P.
Bille, Jacques
Sanglard, Dominique
Source :
Antimicrobial Agents and Chemotherapy; May 2003, Vol. 47 Issue: 5 p1565-1570, 6p
Publication Year :
2003

Abstract

ABSTRACTThe combination of fluconazole (FLC) and cyclosporine (CY) is fungicidal in FLC-susceptible C. albicans(O. Marchetti, P. Moreillon, M. P. Glauser, J. Bille, and D. Sanglard, Antimicrob. Agents Chemother. 44:2373-2381, 2000). The mechanism of this synergism is unknown. CY has several cellular targets including multidrug efflux transporters. The hypothesis that CY might inhibit FLC efflux was investigated by comparing the effect of FLC-CY in FLC-susceptible parent CAF2-1 (FLC MIC, 0.25 mg/liter) and in FLC-hypersusceptible mutant DSY1024 (FLC MIC, 0.03 mg/liter), in which the CDR1, CDR2, CaMDR1, and FLU1transporter genes have been selectively deleted. We postulated that a loss of the fungicidal effect of FLC-CY in DSY1024 would confirm the roles of these efflux pumps. Time-kill curve studies showed a more potent fungistatic effect of FLC (P= 0.05 at 48 h with an inoculum of 103CFU/ml) and a more rapid fungicidal effect of FLC-CY (P= 0.05 at 24 h with an inoculum of 103CFU/ml) in the FLC-hypersusceptible mutant compared to those in the parent. Rats with experimental endocarditis were treated for 2 or 5 days with high-dose FLC, high-dose CY, or both drugs combined. FLC monotherapy for 5 days was more effective against the hypersusceptible mutant than against the parent. However, the addition of CY to FLC still conferred a therapeutic advantage in animals infected with mutant DSY1024, as indicated by better survival (P= 0.04 versus the results obtained with FLC) and sterilization of valves and kidneys after a very short (2-day) treatment (P= 0.009 and 0.002, respectively, versus the results obtained with FLC). Both in vitro and in vivo experiments consistently showed that the deletion of the four membrane transporters in DSY1024 did not result in loss of the fungicidal effect of FLC-CY. Yet, the accelerated killing in the mutant suggested a “dual-hit” mechanism involving FLC hypersusceptibility due to the efflux pump elimination and fungicidal activity conferred by CY. Thus, inhibition of multidrug efflux transporters encoded by CDR1, CDR2, CaMDR1, and FLU1genes is not responsible for the fungicidal synergism of FLC-CY. Other cellular targets must be considered.

Details

Language :
English
ISSN :
00664804 and 10986596
Volume :
47
Issue :
5
Database :
Supplemental Index
Journal :
Antimicrobial Agents and Chemotherapy
Publication Type :
Periodical
Accession number :
ejs57149224
Full Text :
https://doi.org/10.1128/AAC.47.5.1565-1570.2003